跳至主要内容
临床试验/CTRI/2019/08/020708
CTRI/2019/08/020708已完成未知

To evaluate the in-vivo safety and efficacy of the skin care formulation in terms of non-comedogenic effect on healthy human subjects - Not Applicable

Alembic Pharmaceuticals Ltd0 个研究点目标入组 34 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Having oily or mixed oily skin on the face.

排除标准

  • -For female: Do not take part in any family planning activities leading to pregnancy and breastfeeding
  • -Do not take part in another study liable to interfere with this study
  • -Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
  • -Do not change her/his cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit.

研究者

发起方
Alembic Pharmaceuticals Ltd

相似试验